HDAC9 and diffuse large B-cell lymphoma: We show that a proteolysis targeting chimera (PROTAC) that combined HDAC inhibitor CI‐994 and an IAP ligand had a strong effect in killing different DLBCL cell lines, being more effective in doing so than CI‐994 on its own.